Bluenote

Accelerating Life-Saving Therapies with AI

Bluenote is a generative AI platform built specifically for the life sciences industry, designed to automate and streamline the creation of regulatory and clinical documentation. By generating first drafts of Clinical Study Reports (CSRs), IND/NDA/BLA modules, and technical reports in minutes rather than days, Bluenote enables pharmaceutical companies, CROs, and medical device manufacturers to redirect their focus from tedious paperwork to scientific research and product development. Backed by a recent $10 million funding round led by Lux Capital and Elad Gil, the company is rapidly expanding its footprint across the healthcare ecosystem, partnering with major players like CMIC and Guardant Health to reduce the time it takes to bring breakthrough therapies to patients.

A Culture of Scientific Rigor and Technical Excellence

At Bluenote, the culture bridges the gap between cutting-edge artificial intelligence and the stringent demands of the life sciences sector. The team is composed of individuals with deep industry expertise and technical sophistication, united by a shared mission to eliminate the friction in regulatory compliance. With co-founders Fatima Sabar and Katsuya Noguchi at the helm, the company fosters an environment where innovation is grounded in factual accuracy and traceability. Employees are encouraged to build solutions that not only push the boundaries of what AI can do but also adhere to the highest standards of patient safety and clinical efficacy.

What You'll Actually Do

Working at Bluenote means building the infrastructure that will power the next generation of drug development. Engineers focus on developing and fine-tuning custom Large Language Models (LLMs) that outperform off-the-shelf models in life sciences applications. You will be responsible for creating AI agents that can handle complex, multi-step workflows, from formatting datasets to translating technical documents. The engineering challenges involve ensuring 100% traceability to source data, maintaining enterprise-grade security (SOC 2 Type II, HIPAA), and designing intuitive interfaces that scientists and regulatory experts can adopt seamlessly. The work is highly impactful, directly contributing to a platform that can accelerate regulatory submissions by up to 75%.

Compensation & Benefits

While specific salary ranges are not publicly disclosed, Bluenote is well-capitalized following its $10 million funding round and is positioned to offer competitive compensation packages typical of early-stage, high-growth AI startups in San Francisco. Employees can expect a mix of base salary and equity, along with standard health benefits. The company operates on a hybrid and on-site model in San Francisco, fostering close collaboration among its technical and domain experts.

The Interview Process

As an early-stage startup, Bluenote's interview process is likely designed to evaluate both technical prowess and a deep understanding of or willingness to learn about the life sciences domain. Candidates can expect an initial screening followed by technical assessments that test their ability to build secure, scalable AI applications. Given the company's focus on enterprise-grade control and data privacy, discussions around building robust, compliant software systems will be a key component of the evaluation. Conversations with the founders and core team members will also assess cultural fit and alignment with the company's mission to transform healthcare workflows.

Why Join / Why Not

Why Join: Bluenote offers a rare opportunity to work at the intersection of generative AI and life sciences, solving a massive, tangible problem that affects the speed at which life-saving therapies reach the market. The company has strong backing from top-tier investors like Lux Capital and Elad Gil, and early traction with significant industry partners. If you are passionate about using AI to make a real-world impact in healthcare, this is an ideal environment to build meaningful technology.

Why Not: The life sciences industry is heavily regulated, which means the pace of product development must account for stringent compliance and security requirements. This environment may not appeal to engineers who prefer the rapid, move-fast-and-break-things ethos of consumer tech. Additionally, as an early-stage startup with a small team (11-50 employees), the role requires a high degree of adaptability and comfort with ambiguity as the company scales its operations and product offerings.